On Thursday, March 19 from 1:30 – 2:30PM Eastern Time, Dr. Steven Treon of the Dana-Farber Cancer Institute and Dr. Christian Buske of University of Ulm, Germany will present a workshop focused on “The Latest News in the Treatment of WM”. You can participate in this informative educational program online or by phone.
Participants may call in to the workshop toll-free within the United States or stream the program online from anywhere in the world. The program is free, but you must register to participate. This will be the 7th collaboration between IWMF and CancerCare in a Connect® Education Workshop on WM. CancerCare is the leading national organization in the U.S. providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer.
Register online here(link is external) or by calling the CancerCare HopeLine at 1-800-813-4673. After you have registered, you will receive additional information containing connection instructions and other details. If you have a scheduling conflict and cannot participate in the teleconference when presented, you will be able to access a recording of the program on the CancerCare website.
The workshop will cover the following topics:
· What’s New in the Treatment of WM
· Symptoms & Signs
· Front Line Treatment of WM
· Treatment for Relapsed/Refractory WM
· Standard of Care & New Treatment Approaches
· Clinical Trial Updates
· Managing Symptoms & Side Effects, Including Controlling Complications
· Managing Peripheral Neuropathy
· Key Questions to Ask Your Health Care Team, including Treatment Follow-Up Care
· Quality-of-Life Concerns
· Mapping the Future of WM
· Questions for Our Panel of Experts
Our Panel of Experts:
Steven Treon, MD, PhD
Director, Bing Center for Waldenstrom’s Macroglobulinemia
Professor, Harvard Medical School
Dana-Farber Cancer Institute
Christian Buske, MD
Medical Director
Comprehensive Cancer Centre and Institute of Experimental Cancer Research
University of Ulm, Germany
Attending Physician & Professor of Medicine
Medical Department for Internal Medicine III
Hematology/Oncology, University Hospital, Ulm, Germany
Carl Harrington
Chair, IWMF Board of Trustees
International Waldenstrom’s Macroglobulinemia Foundation
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training
CancerCare